Summary The importance of axillary dissection as part of the primary surgical procedure in the treatment of operable cases of carcinoma of the breast is established. The morbidity of this procedure, however, is less well documented.
Axillary dissection has a role in the management of early breast cancer as a major prognostic indicator (Fisher & Slack, 1970) , as a guide to the need for adjuvant treatments (Yarnold, 1984) , and therapeutically in reducing the risk of axillary recurrence (Graversen et al., 1988; Kissin et al., 1982; Cady & Sear, 1986 ). It may not, however, influence overall survival rates and knowledge of the morbidity of the procedure is therefore important (Kissin et al., 1986; Brismar & Ljungdahl, 1983; Vecht et al., 1989; Aitken et al., 1989; Andry et al., 1980; Christensen & Lundgren, 1989) . The value of complete axillary dissection, as opposed to nodal sampling or partial dissections, is twofold. Firstly it reduces the risk of local axillary recurrence to less than 5%, lesser procedures carrying a proportionally higher risk of local recurrence, and secondly its predictive value, both of prognosis, and of the necessity for additional axillary radiotherapy, is greater.
This study was performed to assess the morbidity following axillary dissection in terms of numbness, pain, weakness, swelling, and stiffness, both subjectively and objectively.
Material and methods
One hundred and twenty-six consecutive patients attending a Breast Clinic between December 1990 and April 1991 who fulfilled the following criteria were invited to participate in the study.
(1) Had undergone full axillary dissection at six months previously. (Kissin et al., 1986 (Figure 1) , with numbness affecting the majority (70%), whereas pain, weakness, swelling, and stiffness each affected less than one third of the patients.
(2) The variation of pain with time from surgery (Figure 2) , showing a gradual and consistant decrease with time, although this was not statistically significant.
The variation of arm swelling with time (Figure 3) , showing a tendency to increase both subjectively, and objectively, over the first two or four years after surgery and decreasing thereafter. However numbness, specifically over the lateral chest wall, was less common on the dominant (21%) than on the non dominant (46%) side (P = 0.014).
Whilst the graphs in Figures 2, 5, and 6 suggest that pain and numbness tend to decrease with time, the results do not quite achieve statistical significance (P = 0.076 and P = 0.12 respectively).
None of the fifteen control patients gave results outside the reference ranges as defined above.
Discussion
The place and extent of axillary dissection in the management of early breast cancer remains controversial (Fentiman & Mansell, 1991) , and its effect upon long term survival unproven. Morbidity is therefore of major concern. The advantages of full axillary dissection, as opposed to lymph node sampling or lower level dissections, are that it reduces the risk of axillary recurrence to less than 5%, allows more accurate prediction of prognosis and need for adjuvant treatments, and provided that no more than 75% of the removed nodes are histologically positive for metastatic disease, allows axillary radiotherapy to be held in reserve, with consequent reduction in overall morbidity.
The above results show that the side effects of full axillary dissection, including numbness, weakness, pain, swelling, and stiffness are common and so should be mentioned at the time of obtaining consent for the operative procedure. However they also tend to be mild, affecting daily living in approximately one third of patients, and to mitigate with time albeit not to a statistically significant degree in this study. They also suggest strongly that certain side effects, namely swelling and weakness, are more likely to occur if the dominant side is operated upon, whereas numbness is less likely to result. The explanation for these observations is unclear but may be due to chance alone.
The literature concerning the morbidity of management regimes involving incomplete axillary dissections and routine nodal radiotherapy is insufficient to allow direct comparison with the above group and a controlled clinical trial designed so to do would be most unlikely to win ethical approval. Moreover the problems associated with treatment of local axillary relapse in clinical practice highlight the desirability of securing local control from the outset.
In summary the morbidity of full axillary dissection is quantifiable, significant, but seldom severe and, in the opinion of the authors, should not be considered sufficient to outweigh the advantages of improved local control and added prognostic information provided.
